• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge.新冠病毒感染患者出院4个月后持续存在血栓前状态改变。
Blood Adv. 2021 Feb 9;5(3):756-759. doi: 10.1182/bloodadvances.2020003968.
2
Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.与 COVID-19 感染严重程度相关的炎症和血栓形成生物标志物。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621999099. doi: 10.1177/1076029621999099.
3
Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19.极大量细胞外囊泡的传播：重症 COVID-19 患者的组织因子活性
Blood Adv. 2021 Feb 9;5(3):628-634. doi: 10.1182/bloodadvances.2020003308.
4
Correlating COVID-19 severity with biomarker profiles and patient prognosis.将 COVID-19 严重程度与生物标志物谱和患者预后相关联。
Sci Rep. 2024 Sep 27;14(1):22353. doi: 10.1038/s41598-024-71951-w.
5
von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.中重度新冠肺炎患者血管性血友病因子/凝血因子Ⅷ裂解酶轴与静脉血栓栓塞症
Br J Haematol. 2021 Mar;192(6):1097-1100. doi: 10.1111/bjh.17216. Epub 2020 Dec 24.
6
COVID-19 and Hypercoagulability.新型冠状病毒肺炎与高凝状态
Clin Adv Hematol Oncol. 2020 Jul;18(7):386-389.
7
Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.严重慢性肾脏病中纤维蛋白形成增加及纤溶能力受损。
Blood Coagul Fibrinolysis. 2016 Jun;27(4):401-7. doi: 10.1097/MBC.0000000000000462.
8
Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.Covid-19：纤维蛋白（ogen）、D-二聚体、血管性血友病因子、P-选择素及其与内皮细胞、血小板和红细胞相互作用的过山车。
Int J Mol Sci. 2020 Jul 21;21(14):5168. doi: 10.3390/ijms21145168.
9
Effects of dark chocolate consumption on the prothrombotic response to acute psychosocial stress in healthy men.食用黑巧克力对健康男性急性心理社会应激促血栓形成反应的影响。
Thromb Haemost. 2014 Dec;112(6):1151-8. doi: 10.1160/TH14-05-0450. Epub 2014 Sep 11.
10
Venous occlusion does not release von Willebrand factor, factor VIII or PAI-1 from endothelial cells--the importance of consensus on the use of correction factors for haemoconcentration.静脉阻塞不会从内皮细胞释放血管性血友病因子、凝血因子VIII或纤溶酶原激活物抑制剂-1——关于血液浓缩校正因子使用共识的重要性。
Thromb Haemost. 1993 Jan 11;69(1):91, 93.

引用本文的文献

1
Increased Anticoagulant Requirement in Total Hip Replacement Patients Post-COVID: A Comparative Study in the Indian Population.新冠疫情后全髋关节置换患者抗凝需求增加：印度人群的一项对比研究。
J Orthop Case Rep. 2025 Jul;15(7):222-230. doi: 10.13107/jocr.2025.v15.i07.5832.
2
Patient-reported treatment outcomes in ME/CFS and long COVID.肌痛性脑脊髓炎/慢性疲劳综合征（ME/CFS）和长期新冠患者报告的治疗结果。
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2426874122. doi: 10.1073/pnas.2426874122. Epub 2025 Jul 8.
3
Sustained Expression of Plasminogen Activator Inhibitor-1 in Patients Recovered from COVID-19 Disease.新冠康复患者中纤溶酶原激活物抑制剂-1的持续表达
Med Princ Pract. 2025 May 21:1-12. doi: 10.1159/000546399.
4
The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID/post-acute sequelae of SARS-CoV-2 infection.在新型冠状病毒肺炎（COVID-19）急性感染期及随后出现新型冠状病毒感染长期后遗症/急性后遗症时使用口服抗凝剂的情况。
J Thromb Thrombolysis. 2025 Apr;58(4):585-589. doi: 10.1007/s11239-025-03096-0. Epub 2025 Apr 5.
5
The Impact of COVID-19 Infection on the Development of Stroke, Pulmonary Embolism, and Myocardial Infarction: A Retrospective Study.新型冠状病毒肺炎感染对中风、肺栓塞和心肌梗死发病的影响：一项回顾性研究
Cureus. 2025 Jan 19;17(1):e77665. doi: 10.7759/cureus.77665. eCollection 2025 Jan.
6
Dynamics of coagulation proteins upon ICU admission and after one year of recovery from COVID-19: a preliminary study.COVID-19患者入住重症监护病房时及康复一年后凝血蛋白的动态变化：一项初步研究。
Front Cell Infect Microbiol. 2025 Jan 8;14:1489936. doi: 10.3389/fcimb.2024.1489936. eCollection 2024.
7
Effects of COVID-19 on short-term outcomes of hip arthroplasty: a multicenter, retrospective, propensity score matched study.新型冠状病毒肺炎对髋关节置换短期预后的影响：一项多中心、回顾性、倾向评分匹配研究
BMC Musculoskelet Disord. 2025 Jan 9;26(1):36. doi: 10.1186/s12891-024-08268-2.
8
Oneyear longitudinal study on biomarkers of blood-brain barrier permeability in COVID-19 patients.一项关于 COVID-19 患者血脑屏障通透性生物标志物的为期一年的纵向研究。
Sci Rep. 2024 Sep 30;14(1):22735. doi: 10.1038/s41598-024-73321-y.
9
Portal Vein Thrombosis in COVID-19: An Underdiagnosed Disease?新型冠状病毒肺炎中的门静脉血栓形成：一种诊断不足的疾病？
J Clin Med. 2024 Sep 21;13(18):5599. doi: 10.3390/jcm13185599.
10
Correlating COVID-19 severity with biomarker profiles and patient prognosis.将 COVID-19 严重程度与生物标志物谱和患者预后相关联。
Sci Rep. 2024 Sep 27;14(1):22353. doi: 10.1038/s41598-024-71951-w.

本文引用的文献

1
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality.新冠肺炎患者的血栓前状态改变与疾病严重程度和死亡率相关。
Res Pract Thromb Haemost. 2020 Dec 6;5(1):132-141. doi: 10.1002/rth2.12462. eCollection 2021 Jan.
2
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?新型冠状病毒感染3个月后仍存在的症状：新冠后综合征？
ERJ Open Res. 2020 Oct 26;6(4). doi: 10.1183/23120541.00542-2020. eCollection 2020 Oct.
3
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.COVID-19 住院后出院后持续存在的症状和与健康相关的生活质量。
J Infect. 2020 Dec;81(6):e4-e6. doi: 10.1016/j.jinf.2020.08.029. Epub 2020 Aug 25.
4
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation.COVID-19 患者抗凝治疗过程中体外高凝状态和体内凝血及纤溶持续激活。
J Thromb Haemost. 2020 Oct;18(10):2646-2653. doi: 10.1111/jth.15043. Epub 2020 Sep 1.
5
Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation.COVID-19 感染幸存者出院后的症状和康复需求：一项横断面评估。
J Med Virol. 2021 Feb;93(2):1013-1022. doi: 10.1002/jmv.26368. Epub 2020 Aug 17.
6
Thrombosis and coagulopathy in COVID-19: An illustrated review.新型冠状病毒肺炎中的血栓形成与凝血病：图文综述
Res Pract Thromb Haemost. 2020 Jul 11;4(5):744-751. doi: 10.1002/rth2.12400. eCollection 2020 Jul.
7
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis.低纤维蛋白溶解状态和高凝血酶生成可能在 SARS-COV2 相关血栓形成中起主要作用。
J Thromb Haemost. 2020 Sep;18(9):2215-2219. doi: 10.1111/jth.15016. Epub 2020 Aug 11.
8
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.新冠病毒肺炎分类及预后评估中的血液学特征与危险因素：一项回顾性队列研究
Lancet Haematol. 2020 Sep;7(9):e671-e678. doi: 10.1016/S2352-3026(20)30217-9. Epub 2020 Jul 10.
9
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses.新型冠状病毒和其他大流行病毒感染患者的凝血异常和血栓形成。
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2033-2044. doi: 10.1161/ATVBAHA.120.314514. Epub 2020 Jul 13.
10
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.

Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge.

作者信息

von Meijenfeldt Fien A, Havervall Sebastian, Adelmeijer Jelle, Lundström Annika, Magnusson Maria, Mackman Nigel, Thalin Charlotte, Lisman Ton

机构信息

Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Division of Internal Medicine, Department of Clinical Sciences and.

出版信息

Blood Adv. 2021 Feb 9;5(3):756-759. doi: 10.1182/bloodadvances.2020003968.

DOI:10.1182/bloodadvances.2020003968
PMID:33560386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857699/
Abstract
摘要